Surgery Websites
Transplant Surgery »  Meet the Team »  Basic Scientists »  Minnie M. Sarwal M.D., Ph.D.
Minnie M. Sarwal M.D., Ph.D., FRCP, DCH

Minnie M. Sarwal M.D., Ph.D., FRCP, DCH

Professor in Residence, Surgery, Medicine, Pediatrics
Professor (Adj), Stanford University, UC Berkeley
Director, Precision Transplant Medicine, UCSF
Co-Director, T32 Training Grant, Transplant Surgery, UCSF

Contact Information

Box 0780
513 Parnassus Ave, Med Sci Room S1268
San Francisco, CA 94143
minnie.sarwal@ucsf.edu
Open Popup
  • La Martiniere, Calcutta, India, English Language and Literature, I.S.C.,1981
  • Calcutta Medical College, Calcutta, India, M.D.,1985
  • Diploma in Child Health (D.C.H.), London, UK, with distinction 1989
  • Cambridge University, U.K, Ph.D.,1995
  • Residency (Medicine and Surgery), Calcutta Medical College, India, 06/1986-06/1987
  • Senior House Officer (Pediatrics and Surgery), Calcutta Medical College, India. Advisors: Sir Keith Peters, Sir Cyril Chantler and Sydney Brenner, 06/1987-02/1988
  • Senior House Officer, General Pediatrics & Neonates, Good Hope Hospital, Sutton Coldfield, Birmingham, UK, 02/-07/1989
  • Senior House Officer, General Pediatrics & Neonates, Grantham and Kesteven Hospital, Granthan (GKGH), UK, 03/1988-02/1989
  • Senior House Officer, Neonatology, Leicester Royal Infirmary (LRI), Leicester, UK, 08/-11/1989
  • Senior House Officer, General Pediatrics & Neonates, Leicester General Hosp. (LGH), Leicester, UK, 12/89- 03/90
  • Registrar, Pediatric Cardiology and Cardiothoracic Surgical Unit, Groby Road Hospital, (GRH), Leicester, UK, 04/90-07/90
  • Senior House Officer, Pediatric Nephrology Unit, Guy's Hospital, London, UK, 08/90-10/90
  • Lecturer/Registrar, Pediatric Unit, Guy's Hospital, London, UK, 10/90-09/91
  • Lecturer/Senior Registrar,  Pediatric Nephrology, Dept. of Pediatrics, Guy's Hospital, London, U.K., 10/92-07/95
  • Fellowship in Nephrology, Department of Pediatrics, Addenbrooke's Hospital, Cambridge, 10/91-09/92
  • Ph.D., Molecular Genetics Unit, Christs College, Cambridge University, 10/92-12/95 
  • Acute Kidney Failure
  • Chronic Kidney Disease
  • Cystinosis
  • End-Stage Renal Disease
  • Kidney Transplant Clinical Trials
  • Methylmalonic acidemia
  • Oxalosis
  • Pediatric Bone and Mineral Disorders
  • Pediatric Kidney Transplantation
  • Pediatric Transplant Nephrology
  • Transplant Immunology
  • Genomics
  • Antibiomics
  • GVHD
  • Hepatitis B, C and HIV
  • Metabolomics
  • Organ diseases
  • Proteomics
  • Transplant immunobiology of rejection and tolerance
  • Hindi, Punjab

Minnie M. Sarwal M.D., Ph.D., FRCP, DCH is professor of Surgery, director of the Sarwal Lab, and Precision Transplant Medicine at UCSF. Sarwal is a nationally and internationally recognized leader in the fields of renal and transplant medicine, genomics, proteomics and immunology. She as a deep passion for improving the health of organ transplant recipients by discovering new treatments and investigative approaches for improving outcomes. Prior to joining UCSF, Sarwal was Professor of Surgery, Pediatrics and Immunology at Stanford University, Medical Director of the Pediatric Kidney Transplant Program at Lucille Packard Children's Hospital and Director of the Sarwal Lab.

Sarwal received her M.D. from Calcutta Medical College in India, completed her residency in the UK, and a fellowship in Pediatric Nephrology at Guy's Hospital, London, UK. She earned her Ph.D. in Molecular Genetics from Cambridge University (Christ's College) where she worked with Nobel Laureate Sydney Brenner on the synthetic mapping of human and puffer fish G proteins. Sarwal also holds a Diploma in Child Health from London, UK, and membership in the Royal College of Physicians, UK (MRCP). In 2009, she was formally elected as a Fellow of the Royal College of Physicians, UK in recognition of her outstanding contributions to the field of medicine.

Sarwal is a member of numerous national and international societies including the ASN, IPTA, AST, TTS, and IPNA. She has served as Associate Editor of American Journal of Transplantation and as a reviewer for Lancet, Nature Medicine, NEJM, Transplantation, Nature Genetics, PNAS, Kidney International and other prestigious peer-reviewed journals. Sarwal has also been the recipient of numerous awards and distinctions, including the Order of Excellence in Scientific Research (Cambridge, UK, 2002), the Dean's Teaching Award (2005), the Junior Faculty Award from the CCIS (2003-6), a Key Opinion Leader in Organ Transplantation by the Transplantation Society (2007-2009), an elected Senator at Large for the Stanford Faculty Senate (2005-10), the TTS-Roche Award for Outstanding Achievement Transplantation Science (Clinical; 2010), and the Cunio Richardson NKF Award for Scientific Excellence (2012).

  • Councillor, The Transplantation Society, 2014
  • Cunio Richardson Award for Clinical and Research Excellence, The National Kidney Foundation, 2012
  • TTS-Roche Award for Outstanding Achievement in Transplantation Science (Clinical), The Transplantation Society, 2010
  • KOL in Organ Transplantation, The Transplantation Society, 2007-2010
  • Senator At Large, Stanford University Faculty Senate, Stanford University, USA, 2005-2010
  • Deans Award for Resident Education, Stanford University, USA, 2005
  • Faculty Development Award, CCIS, Stanford University, USA, 2003-2006
  • Order of Excellence, Cambridge University, UK, 2002
  • NKF Fellowship, National Kidney Foundation, UK, 1993-1995
  • MRC Fellowship, Medical Research Council, UK, 1991-1992
View all

As principal Investigator on numerous multicenter clinical trials, both industry and institutional, Sarwal has developed extensive expertise in the design and execution of clinical studies. While at Stanford, Sarwal conducted the first successful U.S. steroid avoidance trial and the first dosing safety trial for Rituximab in pediatric renal transplantation.

In 2009, Sarwal founded, Organ-i, a Stanford University spin-out to develop and commercialize her pioneering work. Organ-i leveraged 15 years of research and over $20M in NIH grants. The company's goal is to improve the clinical management of transplant patients globally by commericializing non-invasive tests to monitor and predict organ health for transplant recipients.

Sarwal is credited with the introduction of (k-SORT), a Kidney Solid Organ Rejection Test, the company's lead product, as well as a pipeline of molecular assays focused on post-transplant rejection monitoring and allograft tolerance. In June 2014. Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced the acquisition of Organ-i and retained Sarwal as a scientific advisory role to advance the Organ-i pipeline.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 219
Publications provided by UCSF Profiles, powered by CTSI.
  1. Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci Transl Med. 2020 Mar 18; 12(535). View in PubMed
  2. Mannon RB, Morris RE, Abecassis M, Axelrod D, Bala S, Friedman GS, Heeger PS, Lentine KL, Loupy A, Murphy B, Nickerson P, Sarwal M, O'Doherty I, Spear N, Karpen SR. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report. Am J Transplant. 2020 Feb 24. View in PubMed
  3. Roll GR, Posselt AM, Freise J, Baird J, Syed S, Mo Kang S, Hirose R, Szot GL, Zarinsefat A, Feng S, Worner G, Sarwal M, Stock PG. Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus. Am J Transplant. 2020 Jan 28. View in PubMed
  4. Yang JYC, Sarwal RD, Ky K, Dong V, Stoller M, Sarwal MM, Chi T. Non-radiological assessment of kidney stones using the kidney injury test (KIT), a spot urine assay. BJU Int. 2020 May; 125(5):732-738. View in PubMed
  5. Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Front Med (Lausanne). 2019; 6:213. View in PubMed
  6. View All Publications

 

Site Directory
    X